Home

WILLIAM S REARDON

CIK 1212646 · last filed 2021-04-08

WILLIAM S REARDON is a corporate insider who has filed 46 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider exercised options on $6.9K of THW on Apr 8, 2021. Across all open-market trades the lifetime net is +$158.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $93.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$93.0K

Companies

8

Total Filings

46

Lifetime Open-Market Net

$158.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
THW Director 1,946 $13.12 $25.5K $25.0K 2 2021-04-08
THQ Director 1,196 $18.55 $22.2K $24.9K 1 2021-03-01
Aceragen, Inc. (IDRA) Delisted Director 1,940 $7.22 $14.0K $26.4K 20 2018-06-22
MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted Director 47,120 — — $50.0K 10 2015-07-06
HQL Director 1,612 $19.25 $31.0K $14.2K 2 2014-07-01
HQH Director 661 $21.50 $14.2K $10.2K 1 2012-03-12
OSCIENT PHARMACEUTICALS CORP (OSCI) Delisted Director 2,553 — — $0 2 2008-06-13
Aceragen, Inc. (IDP) Delisted Director 4,008 — — $7.8K 8 2007-10-03

Recent Filings

46 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-04-08 THW Exer (X) +486 $6.9K EDGAR
2021-03-01 THW Buy (P) +1,460 $25.0K EDGAR
2021-03-01 THQ Buy (P) +1,196 $24.9K EDGAR
2018-06-22 Aceragen, Inc. (IDRA) Delisted Grant (A) — $0 EDGAR
2017-07-07 Aceragen, Inc. (IDRA) Delisted Grant (A) +7,714 $13.5K EDGAR
2017-06-09 Aceragen, Inc. (IDRA) Delisted Grant (A) — $0 EDGAR
2016-07-06 Aceragen, Inc. (IDRA) Delisted Grant (A) +4,102 $6.7K EDGAR
2016-06-15 Aceragen, Inc. (IDRA) Delisted Grant (A) — $0 EDGAR
2015-07-06 MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted Grant (A) +7,953 $0 EDGAR
2015-06-10 Aceragen, Inc. (IDRA) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 46
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.